Abstract
G‐quadruplexes form folded structures because of tandem repeats of guanine sequences in DNA or RNA. They adopt a variety of conformations, depending on many factors, including the type of loops and cations, the nucleotide strand number, and the main strand polarity of the G‐quadruplex. Meanwhile, the different conformations of G‐quadruplexes have certain influences on their biological functions, such as the inhibition of transcription, translation, and DNA replication. In addition, G‐quadruplex binding proteins also affect the structure and function of G‐quadruplexes. Some chemically synthesized G‐quadruplex sequences have been shown to have biological activities. For example, bimolecular G‐quadruplexes of AS1411 act as targets of exogenous drugs that inhibit the proliferation of malignant tumours. G‐quadruplexes are also used as vehicles to deliver nanoparticles. Thus, it is important to identify the factors that influence G‐quadruplex structures and maintain the stability of G‐quadruplexes. Herein, we mainly discuss the factors influencing G‐quadruplexes and the synthetic G‐quadruplex, AS1411.
Significance of the study
This review summarizes the factors that influence G‐quadruplexes and the functions of the synthetic G‐quadruplex, AS1411. It also discusses the use of G‐quadruplexes for drug delivery in tumour therapy.
Keywords: AS1411, G‐quadruplex, G‐tetrad, nanoparticles
1. INTRODUCTION
The G‐quadruplex, which is formed by the folding of tandem repeats of guanine sequences,1 is a special secondary structure of DNA and RNA. As a square plane, the G‐tetrad, which is the structural unit of G‐quadruplexes, is formed by connecting four guanines through eight hydrogen bonds. In the G‐tetrad, two hydrogen bonds pairing adjacent guanines are involved in N1, N7, O6, and N2 of each guanine nucleotide (Figure 1A).2, 3, 4, 5 These G‐tetrads are connected by four G‐tracts, which denote four separate runs of three guanines. In addition to the quadrimolecular G‐quadruplex, the intervening sequences connecting two adjacent G‐tracts are pushed out to form a single‐stranded loop (Figure 1B).3 Two or more G‐tetrads that are parallel to each other are stacked to form a G‐quadruplex. Because of the 2′‐hydroxyl group of the ribose in the pentose phosphate skeleton, the G‐quadruplexes of RNA are more thermodynamically stable in different environments than G‐quadruplexes of DNA with the same sequences. RNA G‐quadruplexes almost exclusively adopt a parallel quadrimolecular conformation.3, 6, 7, 8, 9 However, the conformation of DNA G‐quadruplexes is influenced by many factors. The three main factors are the number of nucleotide strands, the polarity of the main strands of the G‐quadruplexes, and the type of loops.10, 11 Furthermore, cations and G‐quadruplex binding proteins also have important effects on the conformation of G‐quadruplexes.12, 13, 14
Figure 1.

The structures of G‐quadruplexes. A, Structure of G‐tetrads. The G‐tetrad, the structural unit of the G‐quadruplex, is a square plane formed by connecting four guanines through eight hydrogen bonds. The monovalent cations are represented as blue. B, G‐tracts denote four separate runs of three guanines. The intervening sequences between two G‐tracts in single‐stranded DNA or RNA are pushed out to form single‐stranded loops (Nx: N denotes any of A, G, C, T, or U; 1 < x < 7). The loops are represented as red. The G‐quadruplex is formed by the folding of the four G‐tracts of three tandem repeats of guanine sequences separated by loop regions
The human genome harbours >376 000 potential G‐quadruplex sequences,15, 16 which are widely distributed in many important gene regions, such as telomeres, gene promoter regions, and replication origins.12, 13, 17, 18 The G‐quadruplexes in these regions have important biological functions, mainly involving the inhibition of telomerase activity and the regulation of transcription, translation, and DNA replication.9, 19, 20 The G‐quadruplex is regarded as an important drug for cancer treatment.21 Some chemically synthesized G‐quadruplex sequences have been shown to have biological activity. For example, the synthetic G‐quadruplex, AS1411 is used as an exogenous drug to inhibit the proliferation of malignant tumours, with no effect on normal cells.22, 23 In recent years, the number of studies of AS1411 has gradually increased, mainly focusing on its use as a nanoparticle (NP) delivery vehicle or for targeted cancer treatment.24 G‐quadruplexes have good development prospects for the treatment of diseases. Since different conformations of G‐quadruplexes influence their stability and function, it is important to know what factors influence G‐quadruplex structures.
2. FACTORS INFLUENCING G‐QUADRUPLEX STRUCTURE
2.1. The number of nucleotide strands forming the G‐quadruplex
Based on the number of nucleotide strands forming G‐quadruplexes, there are three main types of G‐quadruplex structures: quadrimolecular, bimolecular, and unimolecular. The quadrimolecular G‐quadruplex consists of four independent strands; the bimolecular G‐quadruplex consists of two strands; and the unimolecular G‐quadruplex consists of one strand, which belongs to the intramolecular G‐quadruplex. The quadrimolecular and bimolecular G‐quadruplexes belong to the intermolecular type of G‐quadruplexes (Figure 2).14, 25, 26, 27 Moreover, the long single strand that forms the unimolecular G‐quadruplex can also form bimolecular and quadrimolecular G‐quadruplexes. Intramolecular G‐quadruplexes are predicted to contain at least four G‐tracts in which each G‐tract contains at least three guanine nucleotides (G ≥ 3–Nx –G ≥ 3–Nx–G ≥ 3–Nx–G ≥ 3; N denotes any of A, G, C, T, or U; 1 < x < 7). Otherwise, the stability may be low if each G‐tract only contains only two guanine nucleotides.3 However, for intermolecular G‐quadruplexes, it is possible for each G‐tract to only contain two guanine nucleotides. For example, some studies have shown that the synthetic G‐quadruplex of AS1411 is stable in the presence of serum‐containing medium.
Figure 2.

The number of nucleotide strands forming the G‐quadruplex. A, Quadrimolecular G‐quadruplexes consist of four independent strands and are intermolecular G‐quadruplexes. B, Bimolecular G‐quadruplexes consist of two strands, and they are intermolecular G‐quadruplexes. C, Unimolecular G‐quadruplexes consist of one strand, and they are intramolecular G‐quadruplexes
2.2. The polarity of nucleotide strands
Under different environmental conditions, three typical configurations of G‐quadruplexes are formed, namely, parallel, antiparallel, and mixed configurations.6, 21 Four guanines, connected by hydrogen bonds to form a G‐tetrad, adopt anti or syn arrangements about glycosidic bonds, depending on the glycoside angle of the guanines. The H8 and sugar H1′protons of anti guanine glycoside angles have a longer distance than those of the syn arrangement (Figure 3A and 3B).25 Moreover, the polarities of the relative nucleotide strands forming the G‐quadruplexes are also related to the glycosidic angles of guanines in the same G‐tetrad. The guanine arrangement of each G‐tract can be influenced by monovalent cations.4 For quadrimolecular DNA G‐quadruplexes, if four G‐tracts of one G‐quadruplex have the same polarity, a parallel G‐quadruplex is formed. With K+ or Na+ as the coordinated monovalent cation, the glycosidic angles of the four guanines in each G‐tetrad mainly adopt anti‐anti‐anti‐anti arrangements, and the guanines of each G‐tract adopt anti‐anti‐anti arrangements (Figure 3C).4, 28 For unimolecular G‐quadruplexes, if three of the four G‐tracts have the same polarity and the fourth has the opposite polarity, mixed G‐quadruplexes are formed. With Na+ as the coordinated monovalent cation, the glycosidic angles of the four guanines in each G‐tetrad adopt syn‐anti‐anti‐anti or anti‐syn‐syn‐syn arrangements, and the guanines of each G‐tract adopt syn‐anti‐anti or syn‐syn‐anti arrangements (Figure 3D).4, 29 For unimolecular and bimolecular G‐quadruplexes, if two of the four G‐tracts of each G‐quadruplex have the same polarity, an antiparallel G‐quadruplex is formed; therefore, each G‐tract has adjacent parallel or antiparallel neighbours. The glycosidic angles of the four guanines in each G‐tetrad adopt syn–syn–anti–anti30, 31, 32 or syn–anti–syn–anti arrangements.33, 34, 35, 36 However, the guanine arrangement of each G‐tract is different between unimolecular and bimolecular G‐quadruplexes. For unimolecular G‐quadruplexes, the guanines of each G‐tract adopt anti–syn–anti or syn–anti–syn arrangements, with Na+ as the coordinated monovalent cation (Figure 3E). For bimolecular G‐quadruplexes, the guanines of each G‐tract adopt syn–anti–anti or syn–syn–anti arrangements, with K+ or Na+ as the coordinated monovalent cation (Figure 3F).4 Because of the 2′‐hydroxyl group of the ribose in the pentose phosphate skeleton, RNA G‐quadruplexes prefer to form parallel G‐quadruplexes, which are unaffected by the surrounding conditions.2, 37, 38, 39, 40, 41
Figure 3.

The polarity of nucleotide strands forming the G‐quadruplex. A, The anti arrangements of guanine glycoside angles. B, The syn arrangements of guanine glycoside angles. C, The structure of parallel G‐quadruplexes. The four G‐tracts of the parallel quadrimolecular DNA G‐quadruplex have the same polarity. D, The structure of mixed G‐quadruplexes. Three of the four G‐tracts of the unimolecular G‐quadruplex have the same polarity, and the fourth has the opposite polarity. E, The structure of antiparallel G‐quadruplexes. Two of the four G‐tracts of the unimolecular G‐quadruplex have the same polarity. F, The structure of antiparallel G‐quadruplexes. Two of the four G‐tracts of the bimolecular G‐quadruplex have the same polarity. The anti guanines are represented as orange, and the syn guanines are represented as grey
2.3. The loop of G‐quadruplexes
The intervening sequences between two G‐tracts in single‐stranded DNA or RNA are pushed out to form single‐stranded loops.1, 3 The size of the loop affects the stability of the G‐quadruplex structure. One loop generally includes one to seven nucleotides. A smaller loop results in greater stability of RNA G‐quadruplexes, whereas DNA G‐quadruplexes have greater stability with a longer loop.38, 42 The loop is a linker that connects G‐tracts, and it mainly occurs in bimolecular and unimolecular G‐quadruplexes. There are three main types of loops in G‐quadruplexes, namely, chain reversal, lateral, and diagonal loops.43 The chain reversal loop is located on the side of the G‐quadruplex. It is a linker that connects two adjacent parallel strands and two guanine nucleotides that are located on the uppermost and lowermost G‐tetrads (Figure 4A).29, 44, 45 The lateral loop connects two adjacent antiparallel strands and two adjacent guanine nucleotides located on the same G‐tetrad. These two adjacent guanine nucleotides are connected by two hydrogen bonds to form one edge of the G‐tetrad (Figure 4B).31, 46 The diagonal loop connects two opposing antiparallel strands and two opposing guanine nucleotides located on the same G‐tetrad (Figure 4C).30, 32 In addition, the mixed unimolecular G‐quadruplex forms a special v‐shaped loop between two adjacent guanine nucleotides located on the uppermost G‐tetrad (Figure 4D).47 Because of the different types of loops, the antiparallel unimolecular G‐quadruplex presents two different configurations, namely, chair and basket configurations (Figure 4E and 4F).
Figure 4.

The loop of G‐quadruplexes. A, The chain reversal loop. B, The lateral loop. C, The diagonal loop. D, The v‐shaped loop. The loops are represented as red. E, Basket configurations of the antiparallel unimolecular G‐quadruplex. F, Chair configurations of the antiparallel unimolecular G‐quadruplex
2.4. The effect of cations on G‐quadruplexes
The formation and stability of G‐quadruplexes are affected by monovalent cations, including K+, Na+, Rb+, Cs+, NH4+, and Tl+, and divalent cations. K+ and Na+ are the most extensively characterized monovalent cations. However, compared with Na+, G‐quadruplexes prefer K+, because of its radius and free energy.48 K+ enters the middle of two adjacent G‐tetrads and binds to eight carbonyl oxygen atoms. It can neutralize the negative electrostatic potential energy generated by the oxygen atoms in eight guanine nucleotides.32, 49 The radius of Na+ is smaller than that of K+, and therefore, Na+ enters directly into a G‐tetrad. Under these conditions, it only neutralizes the negative electrostatic potential energy produced by the oxygen atoms in four guanine nucleotides. Na+ also increases the stability of G‐quadruplexes, although to a lesser extent than K+.14, 49, 50 Therefore, monovalent cations improve the stability of G‐quadruplexes, seemingly due to their radius. A free energy cycle, which includes the free energy of hydration and the relative free energy of ion replacement, influences the ion selectivity of G‐quadruplexes. Hud et al48 reported that Na+ actually binds to the G‐quadruplex coordination site with a higher relative free energy of ion replacement than K+, whereas the negative hydration free energy of Na+ is greater. Considering the free energy cycle as a whole, K+ can replace the position of Na+. Divalent cations also promote the formation of G‐quadruplexes and stabilize their structure but with a more complex mechanism than that of monovalent cations. Divalent cations stabilize G‐quadruplexes in the following order: Sr2+ > Ba2+ > Ca2+ > Mg2+.51, 52 When other cations are absent, Ca2+ and Mg2+ do not have the ability to promoting the formation of G‐quadruplexes. In addition, the concentration of divalent cations also affects the stability of G‐quadruplexes. Lower concentrations of divalent cations lead to more stable G‐quadruplex structures.49 The ion radius of Sr2+ is close to that of K+, and for some unimolecular G‐quadruplexes, Sr2+ plays a more important stabilizing role than K+.53, 54, 55
3. G‐QUADRUPLEXES AND G‐QUADRUPLEX BINDING PROTEINS
Helicases are molecular motors that use ATP‐driven motor force.56, 57, 58, 59 On one hand, helicases unwind the double helices of DNA or complementary RNA to promote the formation of single‐stranded nucleic acids. On the other hand, some helicases also have the ability to rewind or re‐anneal two complementary single‐stranded DNA or RNA molecules.60 Helicases play a role in almost every aspect of DNA and RNA metabolism, including replication, repair, recombination, transcription, chromosome segregation, and telomere maintenance.61, 62, 63, 64 During DNA replication, replication helicases unwind the DNA double helices.60 The leading strand is the template for DNA replication, and its synthesis is continuous. The synthesis of the lagging strand is discontinuous, and therefore, the leading strand transiently remains single‐stranded, which provides a potential opportunity for guanine‐rich strands to fold into stable G‐quadruplexes, especially when DNA replication is slow.3, 5 The G‐quadruplex has beneficial roles in cancer therapy, because of its inhibitory effect on DNA replication. However, it is necessary to unwind G‐quadruplexes in normal cells. Some studies have shown that many helicases bind to and unwind G‐quadruplex structures. The best characterized DNA G‐quadruplex helicases are WRN, BLM, Pif1, and FANCJ. The mutation of DNA G‐quadruplex helicases leads to severe hereditary diseases. These diseases are associated with the loss of G‐quadruplex unwinding, which causes genomic instability. The absence of WRN is associated with premature ageing, and the deletion of BLM, Pif1, or FANCJ is associated with an increased risk of cancer.5, 65, 66, 67, 68, 69 The presence of a G‐quadruplex on the template strand inhibits transcription; however, when it occurs on the complementary strand, the transcription level of some genes increases. In addition, G‐quadruplex binding proteins affect transcription.18 The mammalian oncogene, MYC, is one of the best models to study the effects of G‐quadruplexes on transcription. In 80% of human cancer cells, the expression level of MYC is increased, and this promotes tumourigenesis.70, 71, 72 Guanine‐rich sequences in the promoter region of the C‐MYC gene can be folded to form G‐quadruplexes, which inhibit its expression.73 Nucleolin, a 100 kDa nucleolar phosphoprotein, is abundant in eukaryotic cells. It binds to G‐quadruplexes in the promoter region of C‐MYC and promotes the formation of G‐quadruplexes, which inhibit gene expression.74, 75 During translation, the guanine‐rich sequences of mRNAs have the ability to form G‐quadruplexes, and the main role of these G‐quadruplexes is to inhibit translation.76 Some proteins can bind to RNA G‐quadruplexes and affect translation. DHX36 is an RNA G‐quadruplex helicase, which mainly unwinds RNA G‐quadruplexes.77, 78 PTX1 is a transcription factor associated with cancer. Booy et al showed that the expression of PTX1 increased when the DHX36 gene was knocked out. This may be related to the effects of DHX36 on the G‐quadruplex structure in the 3′‐UTR of PTX1 mRNA.79 Above all, G‐quadruplexes have important biological functions in DNA replication, transcription, and translation. G‐quadruplex binding proteins affect the function of G‐quadruplexes by promoting their formation and stabilizing or unfolding the G‐quadruplex structures.
3.1. The synthetic G‐quadruplex, AS1411
3.1.1. AS1411 acts as an exogenous drug
AS1411, which consists of 26 nucleotides, is a synthetic G‐rich oligodeoxynucleotide with the sequence, 5′‐GGT GGT TGT GGT GG‐3′. It can form bimolecular G‐quadruplexes and acts as an exogenous drug.22, 80 The structure of AS1411 is highly polymorphic in solution, with at least eight different G‐quadruplex structures detected by chromatography and NMR.81 AS1411 is stable in the presence of serum‐containing medium, and fluorescence anisotropy analysis has shown that AS1411 is resistant to nuclease degradation.22, 82, 83, 84 Nucleolin, one of the molecular targets of AS1411,22, 85 acts as a receptor on the cell surface and plays an important role in the transport of substances between the nucleus and cytoplasm.86, 87, 88 The overexpression of nucleolins on the surface of cancer cells is associated with malignant proliferation.89 Moreover, nucleolins are also present in the cytoplasm and nucleus of cancer cells but only in the nucleus of normal cells.90 AS1411 binds to nucleolin to suppress proliferation and induce the death of cancer cells in vitro. This may be due to the inhibition of DNA replication by AS1411, but it may also be linked to the stabilization of BCL‐2 mRNA, which is inhibited by nucleolin.22, 82, 83, 90, 91, 92, 93 A phase I clinical trial demonstrated that AS1411 has no serious toxicity in humans, and it is currently being assessed as an anticancer agent in phase II clinical trials.22 All in all, AS1411 appears to have extensive therapeutic potential, and thus, further studies of G‐quadruplexes are warranted.
3.1.2. AS1411 is used as a vehicle to deliver NPs
During the treatment of various diseases, it is important to effectively deliver drugs to the target sites or cells, to maximize the local concentration of the drug and reduce the potential side effects to other normal sites or cells.94 NPs improve drug effects by increasing drug stability during blood transport and promoting drug absorption into cells.95, 96 Paclitaxel (PTX, also known as taxol), which is isolated from the bark of the Pacific yew, is considered one of the best natural antitumour drugs.97, 98 Because of its low solubility in aqueous environments (<0.03 mg/mL) and chemoresistance, only a small amount of PTX enters tumour cells, and therefore, its clinical application is limited.98, 99 Human serum albumin (HSA) is a plasma protein that is used as a delivery vehicle. It has the advantages of reducing the clearance and degradation of the drug, resulting in higher intratumour concentrations.100, 101, 102, 103 After the structure is destroyed, the hydrophobic domain of HSA is exposed, and the denatured molecules surrounding PTX cause self‐assembly into nanoparticles (NPs‐PTX), through hydrophobic interactions.104 Recently, it was reported that a drug delivery system, Apt‐NPs‐PTX, was formed by modifying NPs‐PTX with AS1411, via cross‐linking with EDC and NHS. This drug delivery system was shown to be very stable. Apt‐NPs‐PTX is transported to the nucleus in combination with nucleolin. It increases the intake rate and inhibitive ability of PTX. Thus, Apt‐NPs‐PTX overcomes the clinical application limitations of PTX, with little effect on normal cells.101 As a promising drug delivery system, the Apt‐NPs‐drug system reduces the side effects of traditional drug delivery systems and simultaneously improves tumour targeting and drug efficacy.
CONCLUSIONS
In recent years, G‐quadruplexes have become a popular research topic globally. Experiments investigating DNA replication and transcription have provided the most convincing evidence to date of the existence of G‐quadruplex structures in vivo.105, 106, 107 Some studies have reported that the formation of DNA G‐quadruplexes may be pathological and may only occur occasionally. This is related to discontinuous lagging strand replication, which provides a potential opportunity for guanine‐rich strands to fold into G‐quadruplex structures, especially when DNA replication is slow. However, the specific processes and mechanisms of G‐quadruplex formation are not clear, and further research is needed. G‐quadruplexes have important biological functions; however, the configuration of the G‐quadruplex depends on many factors. It is important to investigate the influence of such factors and identify a generic modification strategy to maintain the stability of G‐quadruplex structures. Recently, the chemical modification strategy has become a hot topic for future research. Some studies have reported that 2′‐deoxyinosine can be used as a chemical modification strategy, to maintain the chemical stability and promote the biological effects of G‐quadruplexes.
AS1411 appears to have extensive therapeutic potential, and a phase I clinical trial has shown that AS1411 has no serious toxicity in cancer patients. It would be of interest to identify the mechanism whereby AS1411 preferentially affects cancer cells and only has minimal side effects on normal cells. AS1411 is a type of nucleolin‐nucleotide aptamer, and aptamer technology has been developed in the last few decades as a novel therapeutic approach. Furthermore, aptamers can be used as delivery vectors by targeting cell surface markers to deliver drugs, proteins, radionuclides, and NPs into cancer cells.108, 109 Some noncoding RNAs, such as siRNAs and microRNAs, also have therapeutic potential by selectively downregulating gene expression in diseased cells.110, 111, 112 Some studies have shown that AS1411‐microRNA conjugates can be constructed by chemically coupling microRNAs to AS1411 via a linker, and these constructs can be delivered into cancer cells by combining with nucleolins.113 AS1411 provides a new direction for gene therapy. A recent study has shown that the biological activity of an antisense oligonucleotide is dependent on the mechanism of uptake, rather than uptake efficiency.114 AS1411 can combine with nucleolins and enter cancer cells by a process known as macropinocytosis.23 However, the specific site at which AS1411 combines with nucleolins on cancer cells and the reason why cancer cells uptake AS1411 by micropinocytosis are not clear. Thus, further research is needed to explore these mechanisms. From this review, it is clear G‐quadruplexes have many important roles, but there are some specific details of their function that require further study.
CONFLICT OF INTEREST
There are no other conflicts of interest to disclose.
ACKNOWLEDGEMENTS
We thank the Institute of Organ Fibrosis and Targeted Drug Delivery of China, China Three Gorges University and the Hubei Key Laboratory of Tumour Microenvironment and Immunotherapy of China, China Three Gorges University. We are grateful for the financial support of the National Natural Science Foundation of China (no. 81800550 and 81670555); the Chinese Foundation for Hepatitis Prevention and Control of the WBN Research Foundation (no. TQGB20190153); and the Science Research Innovation Foundation of Graduate Student of China, China Three Gorges University (no. 2018SSPY106). The authors thank Shan‐Bing Yin for English language editing.
Yuan W‐F, Wan L‐Y, Peng H, et al. The influencing factors and functions of DNA G‐quadruplexes. Cell Biochem Funct. 2020;38:524–532. 10.1002/cbf.3505
Funding information The science research innovation foundation of graduate student of china three gorges university, Grant/Award Number: 2018SSPY106; Chinese Foundation for Hepatitis Prevention and Control of the WBN Research Foundation, Grant/Award Number: TQGB20190153; National Natural Science Foundation of China, Grant/Award Numbers: 81670555, 81800550
Contributor Information
Wen‐Bing Ai, Email: 1043642574@qq.com.
Jiang‐Feng Wu, Email: jiangfengwu2011@163.com.
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
REFERENCES
- 1. Sundquist WI, Heaphy S. Evidence for interstrand quadruplex formation in the dimerization of human immunodeficiency virus 1 genomic RNA. Proc Natl Acad Sci U S A. 1993;90:3393‐3397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Murat P, Balasubramanian S. Existence and consequences of G‐quadruplex structures in DNA. Curr Opin Genet Dev. 2014;25:22‐29. [DOI] [PubMed] [Google Scholar]
- 3. Bochman ML, Paeschke K, Zakian VA. DNA secondary structures: stability and function of G‐quadruplex structures. Nat Rev Genet. 2012;13:770‐780. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Keniry MA. Quadruplex structures in nucleic acids. Biopolymers. 2001;56:123‐146. [DOI] [PubMed] [Google Scholar]
- 5. Mendoza O. G‐quadruplexes and helicases. Nucleic Acids Res. 2016;44:1989‐2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Burge S, Parkinson GN, Hazel P, Todd AK, Neidle S. Quadruplex DNA: sequence, topology and structure. Nucleic Acids Res. 2006;34:5402‐5415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Collie GW, Haider SM, Neidle S, Parkinson GN. A crystallographic and modelling study of a human telomeric RNA (TERRA) quadruplex. Nucleic Acids Res. 2010;38:5569‐5580. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Collie GW, Sparapani S, Parkinson GN, Neidle S. Structural basis of telomeric RNA quadruplex—acridine ligand recognition. J Am Chem Soc. 2011;133:2721‐2728. [DOI] [PubMed] [Google Scholar]
- 9. Patel DJ, Phan AT, Kuryavyi V. Human telomere, oncogenic promoter and 5'‐UTR G‐quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics. Nucleic Acids Res. 2007;35:7429‐7455. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Mukundan VT, Phan AT. Bulges in G‐quadruplexes: broadening the definition of G‐quadruplex‐forming sequences. J Am Chem Soc. 2013;135:5017‐5028. [DOI] [PubMed] [Google Scholar]
- 11. Beaudoin JD, Jodoin R, Perreault JP. New scoring system to identify RNA G‐quadruplex folding. Nucleic Acids Res. 2014;42:1209‐1223. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Azzalin CM, Reichenbach P, Khoriauli L, Giulotto E, Lingner J. Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science. 2007;318:798‐801. [DOI] [PubMed] [Google Scholar]
- 13. Xu Y, Suzuki Y, Ito K, Komiyama M. Telomeric repeat‐containing RNA structure in living cells. Proc Natl Sci USA. 2010;107:14579‐14584. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Phillips K, Dauter Z, Murchie AI, Lilley DM, Luisi B. The crystal structure of a parallel‐stranded guanine Tetraplex at 0.95 a Ê resolution. J Mol Biol. 1997;273:171‐182. [DOI] [PubMed] [Google Scholar]
- 15. Huppert JL. Prevalence of quadruplexes in the human genome. Nucleic Acids Res. 2005;33:2908‐2916. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Todd AK, Johnston M, Neidle S. Highly prevalent putative quadruplex sequence motifs in human DNA. Nucleic Acids Res. 2005;33:2901‐2907. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Rhodes D. G‐quadruplexes and their regulatory roles in biology. Nucleic Acids Res. 2015;43:8627‐8637. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Qin Y, Hurley LH. Structures, folding patterns, and functions of intramolecular DNA G‐quadruplexes found in eukaryotic promoter regions. Biochimie. 2008;90:1149‐1171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Healy KC. Telomere dynamics and telomerase activation in tumor progression: prospects for prognosis and therapy. Oncol Res. 1995;7:121‐130. [PubMed] [Google Scholar]
- 20. Lopes J, Piazza A, Bermejo R, et al. G‐quadruplex‐induced instability during leading‐strand replication. EMBO J. 2011;30:4033‐4046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Balasubramanian S, Hurley LH, Neidle S. Targeting G‐quadruplexes in gene promoters: a novel anticancer strategy? Nat Rev Drug Discov. 2011;10:261‐275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Bates PJ, Laber DA, Miller DM, Thomas SD, Trent JO. Discovery and development of the G‐rich oligonucleotide AS1411 as a novel treatment for cancer. Exp Mol Pathol. 2009;86:151‐164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Reyes‐Reyes EM, Teng Y, Bates PJ. A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin‐dependent mechanism. Cancer Res. 2010;70:8617‐8629. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Shi H, Huang Y, Zhou H, et al. Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin. Blood. 2007;110:2899‐2906. [DOI] [PubMed] [Google Scholar]
- 25. Bates PJ, Reyes‐Reyes EM, Malik MT, Murphy EM, O'Toole MG, Trent JO. G‐quadruplex oligonucleotide AS1411 as a cancer‐targeting agent: uses and mechanisms. Biochim Biophys Acta Gen Subj. 1861;2017:1414‐1428. [DOI] [PubMed] [Google Scholar]
- 26. Simonsson T, G‐Quadruplex DNA. Structures‐variations on a theme. Biol Chem. 2001;382:621‐628. [DOI] [PubMed] [Google Scholar]
- 27. Chang CC, Wu JY, Chien CW, et al. A fluorescent carbazole derivative: high sensitivity for quadruplex DNA. Anal Chem. 2003;75:6177‐6183. [DOI] [PubMed] [Google Scholar]
- 28. Paramasivan S, Rujan I, Bolton PH. Circular dichroism of quadruplex DNAs: applications to structure, cation effects and ligand binding. Methods. 2007;43:324‐331. [DOI] [PubMed] [Google Scholar]
- 29. Sen D, Gilbert W. Formation of parallel four‐stranded complexes by guanine‐rich motifs in DNA and its implications for meiosis. Nature. 1988;334:364‐366. [DOI] [PubMed] [Google Scholar]
- 30. Wang Y, Patel DJ. Solution structure of the Tetrahymena telomeric repeat d(T2G4)4 G‐tetraplex. Structure. 1994;2:1141‐1156. [DOI] [PubMed] [Google Scholar]
- 31. Smith FW, Feigon J. Quadruplex structure of Oxytricha telomeric DNA oligonucleotides. Nature. 1992;356:164‐168. [DOI] [PubMed] [Google Scholar]
- 32. Wang Y, Patel DJ. Solution structure of the human telomeric repeat d[AG3(T2AG3)3] G‐tetraplex. Structure. 1993;1:263‐282. [DOI] [PubMed] [Google Scholar]
- 33. Haider S, Parkinson GN, Neidle S. Crystal structure of the potassium form of an Oxytricha nova G‐quadruplex. J Mol Biol. 2002;320:189‐200. [DOI] [PubMed] [Google Scholar]
- 34. Sundquist WI, Klug A. Telomeric DNA dimerizes by formation of guanine tetrads between hairpin loops. Nature. 1989;342:825‐829. [DOI] [PubMed] [Google Scholar]
- 35. Williamson JR, Raghuraman MK, Cech TR. Monovalent cation‐induced structure of telomeric DNA: the G‐quartet model. Cell. 1989;59:871‐880. [DOI] [PubMed] [Google Scholar]
- 36. Kelly JA, Feigon J, Yeates TO . Reconciliation of the X‐ray and NMR structures of the thrombin‐binding aptamer d(GGTTGGTGTGGTTGG). J Mol Biol. 1996;256:417‐422. [DOI] [PubMed] [Google Scholar]
- 37. Kettani A, Bouaziz S, Gorin A, Zhao H, Jones RA, Patel DJ. Solution structure of a Na cation stabilized DNA quadruplex containing G.G.G.G and G.C.G.C tetrads formed by G‐G‐G‐C repeats observed in adeno‐associated viral DNA. J Mol Biol. 1998;282:619‐636. [DOI] [PubMed] [Google Scholar]
- 38. Arora A, Maiti S. Differential biophysical behavior of human telomeric RNA and DNA quadruplex. J Phys Chem B. 2009;113:10515‐10520. [DOI] [PubMed] [Google Scholar]
- 39. Joachimi A, Benz A, Hartig JS. A comparison of DNA and RNA quadruplex structures and stabilities. Bioorg Med Chem. 2009;17:6811‐6815. [DOI] [PubMed] [Google Scholar]
- 40. Zhang DH, Zhi GY. Structure monomorphism of RNA G‐quadruplex that is independent of surrounding condition. J Biotechnol. 2010;150:6‐10. [DOI] [PubMed] [Google Scholar]
- 41. Zhang DH, Fujimoto T, Saxena S, Yu HQ, Miyoshi D, Sugimoto N. Monomorphic RNA G‐quadruplex and polymorphic DNA G‐quadruplex structures responding to cellular environmental factors. Biochemistry. 2010;49:4554‐4563. [DOI] [PubMed] [Google Scholar]
- 42. Zhang AY, Bugaut A, Balasubramanian S. A sequence‐independent analysis of the loop length dependence of intramolecular RNA G‐quadruplex stability and topology. Biochemistry. 2011;50:7251‐7258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Huppert JL. Structure, location and interactions of G‐quadruplexes. FEBS J. 2010;277:3452‐3458. [DOI] [PubMed] [Google Scholar]
- 44. Phan AT. Human telomeric G‐quadruplex: structures of DNA and RNA sequences. FEBS J. 2010;277:1107‐1117. [DOI] [PubMed] [Google Scholar]
- 45. Parkinson GN, Lee MP, Neidle S. Crystal structure of parallel quadruplexes from human telomeric DNA. Nature. 2002;417:876‐880. [DOI] [PubMed] [Google Scholar]
- 46. Kettani A, Gorin A, Majumdar A, et al. A dimeric DNA interface stabilized by stacked A.(G.G.G.G).A hexads and coordinated monovalent cations. J Mol Biol. 2000;297:627‐644. [DOI] [PubMed] [Google Scholar]
- 47. Macaya RF, Schultze P, Smith FW, Roe JA, Feigon J. Thrombin‐binding DNA aptamer forms a unimolecular quadruplex structure in solution. Proc Natl Acad Sci U S A. 1993;90:3745‐3749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Zhang N, Gorin A, Majumdar A, et al. V‐shaped scaffold: a new architectural motif identified in an A. (G.G.G.G) pentadcontaining dimeric DNA quadruplex involving stacked G (anti). G (anti). G (anti). G (syn) tetrads. J Mol Biol. 2001;311:1063‐1079. [DOI] [PubMed] [Google Scholar]
- 49. Hud NV, Smith FW, Anet FA, Feigon J. The selectivity for K+ versus Na+ in DNA Quadruplexes is dominated by relative free energies of hydration: a thermodynamic analysis by 1H NMR. Biochemistry. 1996;35:15383‐15390. [DOI] [PubMed] [Google Scholar]
- 50. Hud NV, PLAVEC J. Quadruplex Nucleic Acids. The role of cations in determining quadruplex structure and stability; 2006. 100p. [Google Scholar]
- 51. Smargiasso N, Rosu F, Hsia W, Colson P, Baker ES, Bowers MT, De Pauw E, Gabelica V. G‐Quadruplex DNA Assemblies: loop length, cation identity, and multimer formation. J Am Chem Soc 2008;10208–10216, 130. [DOI] [PubMed] [Google Scholar]
- 52. Hardin CC, Corregan M, Brown BA 2nd, Frederick LN. Cytosine‐cytosine+ base pairing stabilizes DNA quadruplexes and cytosine methylation greatly enhances the effect. Biochemistry. 1993;32:5870‐5880. [DOI] [PubMed] [Google Scholar]
- 53. Blume SW, Guarcello V, Zacharias W, Miller DM. Divalent transition metal cations counteract potassium‐induced quadruplex assembly of oligo(dG) sequences. Nucleic Acids Res. 1997;25:617‐625. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Shafer RH, Smirnov I. Biological aspects of DNA/RNA quadruplexes. Biopolymers. 2000;56:209‐227. [DOI] [PubMed] [Google Scholar]
- 55. Guschlbauer W, Chantot JF, Thiele D. Four‐stranded nucleic acid structures 25 years later: from guanosine gels to telomer DNA. J Biomol Struct Dyn. 1990;8:491‐511. [DOI] [PubMed] [Google Scholar]
- 56. Chen FM. Sr2+ facilitates intermolecular G‐quadruplex formation of telomeric sequences. Biochemistry. 1992;31:3769‐3776. [DOI] [PubMed] [Google Scholar]
- 57. Patel SS, Donmez I. Mechanisms of helicases. J Biol Chem. 2006;281:18265‐18268. [DOI] [PubMed] [Google Scholar]
- 58. Singleton MR, Dillingham MS, Wigley DB. Structure and mechanism of helicases and nucleic acid translocases. Annu Rev Biochem. 2007;76:23‐50. [DOI] [PubMed] [Google Scholar]
- 59. Pyle AM. Translocation and unwinding mechanisms of RNA and DNA helicases. Annu Rev Biophys. 2008;37:317‐336. [DOI] [PubMed] [Google Scholar]
- 60. Lohman TM, Bjornson KP. Mechanisms of helicase‐catalyzed DNA unwinding. Anna Rev Biochem. 1996;65:169‐214. [DOI] [PubMed] [Google Scholar]
- 61. Wu Y. Unwinding and rewinding: double faces of helicase? J Nucleic Acids. 2012;2012:140601. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Bernstein KA. The RecQ DNA helicases in DNA repair. Annu Rev Genet. 2010;44:393‐417. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Dillingham MS. Superfamily I helicases as modular components of DNA‐processing machines. Biochem Soc Trans. 2011;39:413‐423. [DOI] [PubMed] [Google Scholar]
- 64. Jankowsky E. RNA helicases at work: binding and rearranging. Trends Biochem Sci. 2011;36:19‐29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Brosh RM Jr, Bohr VA. Human premature aging, DNA repair and RecQ helicases. Nucleic Acids Res. 2007;35:7527‐7544. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. London TB, Barber LJ, Mosedale G, et al. FANCJ is a structure‐specific DNA helicase associated with the maintenance of genomic G/C tracts. J Biol Chem. 2008;283:36132‐36139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Mohaghegh P, Karow JK, Brosh RM Jr, Bohr VA, Hickson ID. The Bloom's and Werner's syndrome proteins are DNA structure‐specific helicases. Nucleic Acids Res. 2001;29:2843‐2849. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Huber MD, Lee DC, Maizels N. G4 DNA unwinding by BLM and Sgs1p: substrate specificity and substrate‐specific inhibition. Nucleic Acids Res. 2002;30:3954‐3961. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Ribeyre C, Lopes J, Boulé JB, et al. The yeast Pif1 helicase prevents genomic instability caused by G‐quadruplex forming CEB1 sequences in vivo. PLoS Genet. 2009;5:e1000475. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Sanders CM. Human Pif1 helicase is a G‐quadruplex DNA binding protein with G‐quadruplex DNA unwinding activity. Biochem J. 2010;430:119‐128. [DOI] [PubMed] [Google Scholar]
- 71. Pelengaris S, Khan M, Evan GI. Suppression of Myc‐induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell. 2002;109:321‐334. [DOI] [PubMed] [Google Scholar]
- 72. Lutz W, Leon J, Eilers M. Contributions of Myc to tumorigenesis. Biochim Biophys Acta. 1602;2002:61‐71. [DOI] [PubMed] [Google Scholar]
- 73. Hsu ST, Varnai P, Bugaut A, Reszka AP, Neidle S, Balasubramanian S. A G‐rich sequence within the c‐kit oncogene promoter forms a parallel Gquadruplex having asymmetric G‐tetrad dynamics. J Am Chem Soc. 2009;131:13399‐13409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74. Wu Y, Brosh RM Jr. G‐quadruplex nucleic acids and human disease. FEBS J. 2010;277:3470‐3488. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. Hanakahi LA, Sun H, Maizels N. High affinity interactions of nucleolin with G‐G‐paired rDNA. J Biol Chem. 1999;274:15908‐15912. [DOI] [PubMed] [Google Scholar]
- 76. González V, Guo K, Hurley L, Sun D. Identification and characterization of nucleolin as a c‐myc G‐quadruplex‐binding protein. J Biol Chem. 2009;284:23622‐23635. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77. Beaudoin JD, Perreault JP. 5'‐UTR G‐quadruplex structures acting as translational repressors. Nucleic Acids Res. 2010;38:7022‐7036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78. Sissi C, Gatto B, Palumbo M. The evolving world of protein‐G‐quadruplex recognition: a medicinal chemist's perspective. Biochimie. 2011;93:1219‐1230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79. Vaughn JP, Creacy SD, Routh ED, et al. The DEXH protein product of the DHX36 gene is the major source of tetramolecular quadruplex G4‐DNA resolving activity in HeLa cell lysates. J Biol Chem. 2005;280:38117‐38120. [DOI] [PubMed] [Google Scholar]
- 80. Booy EP, Howard R, Marushchak O, et al. The RNA helicase RHAU (DHX36) suppresses expression of the transcription factor PITX1. Nucleic Acids Res. 2014;42:3346‐3361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81. Bunka DH. Development of aptamer therapeutics. Curr Opin Pharmacol. 2010;10:557‐562. [DOI] [PubMed] [Google Scholar]
- 82. Dailey MM, Miller MC, Bates PJ, Lane AN, Trent JO. Resolution and characterization of the structural polymorphism of a single quadruplex‐forming sequence. Nucleic Acids Res. 2010;38:4877‐4888. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83. Fan X, Sun L, Wu Y, Zhang L, Yang Z. Bioactivity of 2′‐deoxyinosine‐incorporated aptamer AS1411. Sci Rep. 2016;6:25799. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84. Dapic V, Bates PJ, Trent JO, Rodger A, Thomas SD, Miller DM. Antiproliferative activity of G‐quartet‐forming oligonucleotides with backbone and sugar modifications. Biochemistry. 2002;41:3676‐3685. [DOI] [PubMed] [Google Scholar]
- 85. Cao Z, Huang CC, Tan W. Nuclease resistance of telomere‐like oligonucleotides monitored in live cells by fluorescence anisotropy imaging. Anal Chem. 2006;78:1478‐1484. [DOI] [PubMed] [Google Scholar]
- 86. Otake Y, Soundararajan S, Sengupta TK, et al. Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. Blood. 2007;109:3069‐3075. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87. Srivastava M, Pollard HB. Molecular dissection of nucleolin's role in growth and cell proliferation: new insights. FASEB J. 1999;13:1911‐1922. [PubMed] [Google Scholar]
- 88. Hovanessian AG, Puvion‐Dutilleul F, Nisole S, et al. The cell‐surface‐expressed nucleolin is associated with the actin cytoskeleton. Exp Cell Res. 2000;261:312‐328. [DOI] [PubMed] [Google Scholar]
- 89. Derenzini M, Sirri V, Trerè D, Ochs RL. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer‐cells. Lab Invest. 1995;73:497‐502. [PubMed] [Google Scholar]
- 90. Soundararajan S, Chen W, Spicer EK, Courtenay‐Luck N, Fernandes DJ. The nucleolin targeting aptamer AS1411 destabilizes Bcl‐2 messenger RNA in human breast cancer cells. Cancer Res. 2008;68:2358‐2365. [DOI] [PubMed] [Google Scholar]
- 91. Girvan AC, Teng Y, Casson LK, et al. AGRO100 inhibits activation of nuclear factor‐kappaB (NF‐kappaB) by forming a complex with NF‐kappaB essential modulator (NEMO) and nucleolin. Mol Cancer Ther. 2006;5:1790‐1799. [DOI] [PubMed] [Google Scholar]
- 92. Xu X, Hamhouyia F, Thomas SD, et al. Inhibition of DNA replication and induction of S phase cell cycle arrest by G‐rich oligonucleotides. J Biol Chem. 2001;276:43221‐43230. [DOI] [PubMed] [Google Scholar]
- 93. Li T, Dong S, Wang E. G‐Quadruplex aptamers with peroxidase‐like DNAzyme functions: which is the best and how does it work? Chem Asian J. 2009;4:918‐922. [DOI] [PubMed] [Google Scholar]
- 94. Fang Z, Wan LY, Chu LY, Zhang YQ, Wu JF. Smart’ nanoparticles as drug delivery systems for applications in tumor therapy. Expert Opin Drug Deliv. 2015;12:1943‐1953. [DOI] [PubMed] [Google Scholar]
- 95. Fernandez‐Montesinos R, Castillo PM, Klippstein R, et al. Chemical synthesis and characterization of silver‐protected vasoactive intestinal peptide nanoparticles. Nanomedicine. 2009;8:919‐930. [DOI] [PubMed] [Google Scholar]
- 96. Fierro IM, de Menezes Alencar MS, Lins Mendes FM, de Souza Mendes Cd, Nunes BF, de Souza Antunes AM. Nanoparticles applied to antineoplastic agents: a patent landscape. Pharm Pat Anal 2014;3:613–623. [DOI] [PubMed] [Google Scholar]
- 97. Hiro J, Inoue Y, Toiyama Y, et al. Possibility of paclitaxel as an alternative radiosensitizer to 5‐fluorouracil for colon cancer. Oncol Rep. 2010;24:1029‐1034. [DOI] [PubMed] [Google Scholar]
- 98. Singh S, Dash AK. Paclitaxel in cancer treatment: perspectives and prospects of its delivery challenges. Crit Rev Ther Drug Carrier Syst. 2009;26:333‐372. [DOI] [PubMed] [Google Scholar]
- 99. Hassan MK, Watari H, Christenson L, Bettuzzi S, Sakuragi N. Intracellular clusterin negatively regulates ovarian chemoresistance: compromised expression sensitizes ovarian cancer cells to paclitaxel. Tumour Biol. 2011;32:1031‐1047. [DOI] [PubMed] [Google Scholar]
- 100. Wu L, Wu J, Zhou Y, Tang X, Du Y, Hu Y. Enhanced antitumor efficacy of cisplatin by tirapazamine‐transferrin conjugate. Int J Pharm. 2012;431:190‐196. [DOI] [PubMed] [Google Scholar]
- 101. Wu J, Song C, Jiang C, Shen X, Qiao Q, Hu Y. Nucleolin targeting AS1411 modified protein nanoparticle for antitumor drugs delivery. Mol Pharm. 2013;10:3555‐3563. [DOI] [PubMed] [Google Scholar]
- 102. Elzoghby AO, Samy WM, Elgindy NA. Albumin‐based nanoparticles as potential controlled release drug delivery systems. J Control Release. 2012;157:168‐182. [DOI] [PubMed] [Google Scholar]
- 103. Hawkins MJ, Soon‐Shiong P, Desai N. Protein nanoparticles as drug carriers in clinical medicine. Adv Drug Deliv Rev. 2008;60:876‐885. [DOI] [PubMed] [Google Scholar]
- 104. Gong G, Xu Y, Zhou Y, et al. Molecular switch for the assembly of lipophilic drug incorporated plasma protein nanoparticles and in vivo image. Biomacromolecules. 2012;13:23‐28. [DOI] [PubMed] [Google Scholar]
- 105. Kruisselbrink E, Guryev V, Brouwer K, Pontier DB, Cuppen E, Tijsterman M. Mutagenic capacity of endogenous G4 DNA underlies genome instability in FANCJ‐defective C. elegans . Curr Biol. 2008;18:900‐905. [DOI] [PubMed] [Google Scholar]
- 106. Cheung I, Schertzer M, Rose A, Lansdorp PM. Disruption of dog‐1 in Caenorhabditis elegans triggers deletions upstream of guanine‐rich DNA. Nat Genet. 2002;31:405‐409. [DOI] [PubMed] [Google Scholar]
- 107. Paeschke K, Capra JA, Zakian VA. DNA replication through G‐quadruplex motifs is promoted by the Saccharomyces cerevisiae Pif1 DNA helicase. Cell. 2011;145:678‐691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108. Liu N, Zhou C, Zhao J, Chen Y. Reversal of paclitaxel resistance in epithelial ovarian carcinoma cells by a MUC1 aptamer‐let‐7i chimera. Cancer Invest. 2012;30:577‐582. [DOI] [PubMed] [Google Scholar]
- 109. Orava EW, Cicmil N, Gariépy J. Delivering cargoes into cancer cells using DNA aptamers targeting internalized surface portals. Biochim Biophys Acta. 1798;2010:2190‐2200. [DOI] [PubMed] [Google Scholar]
- 110. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103:2257‐2261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111. Cullen BR. Transcription and processing of human microRNA precursors. Mol Cell. 2004;16:861‐865. [DOI] [PubMed] [Google Scholar]
- 112. Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell. 2003;113:673‐676. [DOI] [PubMed] [Google Scholar]
- 113. Kim JK, Choi KJ, Lee M, Jo MH, Kim S. Molecular imaging of a cancer‐targeting theragnostics probe using a nucleolin aptamer and microRNA‐221 molecular beacon‐conjugated nanoparticle. Biomaterials. 2012;33:207‐217. [DOI] [PubMed] [Google Scholar]
- 114. Alam MR, Ming X, Dixit V, Fisher M, Chen X, Juliano RL. The biological effect of an antisense oligonucleotide depends on its route of endocytosis and trafficking. Oligonucleotides. 2010;20:103‐109. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
